Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × Has results × Antidepressive Agents, Tricyclic × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Conditions

Neoplasms 1 Depressive Disorder 1

Interventions

Sunitinib 14 exemestane 11 palbociclib 10 Afatinib 10 Rituximab 9 Bevacizumab 9 Leuprolide 8 Erlotinib Hydrochloride 7 Letrozole 6 Blood Specimen Collection 6 enzalutamide 5 Surveys and Questionnaires 5 Standard of Care 5 Drug Therapy 5 Capecitabine 5 Aromatase Inhibitors 5 lorlatinib 4 Trastuzumab 4 Radiotherapy 4 Docetaxel 4 Crizotinib 4 Anastrozole 4 Abiraterone Acetate 4 talazoparib 3 osimertinib 3 avelumab 3 apalutamide 3 Tyrosine Kinase Inhibitors 3 Temozolomide 3 Surgical Procedures, Operative 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01077596 2017-05-30

Carcinogenicity Study of Bupropion

GlaxoSmithKline

50,430 enrolled 23 charts

Depressive Disorder, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡